Clinical effects of colesevelam in hispanic subjects with primary hyperlipidemia and prediabetes

Objective: To evaluate the efficacy and safety of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes. Materials and Methods: A 16-week, randomized, double-blind, placebo-controlled, multinational study evaluating colesevelam in participants with primary hyperlipidemia (low-...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2012

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/22848

Acceso en línea:

https://doi.org/10.3810/pgm.2012.07.2564
https://repository.urosario.edu.co/handle/10336/22848

Palabra clave:

Apolipoprotein B
Colesevelam
Glucose
Hemoglobin a1c
Low density lipoprotein cholesterol
Placebo
Allylamine
Apolipoprotein B
Colesevelam
Drug derivative
Glycosylated hemoglobin
High density lipoprotein
Hypocholesterolemic agent
Low density lipoprotein cholesterol
Abdominal pain
Adult
Article
Backache
Cholesterol blood level
Clinical effectiveness
Clinical evaluation
Constipation
Controlled study
Diarrhea
Dizziness
Double blind procedure
Drug effect
Drug efficacy
Drug safety
Drug tolerability
Dyspepsia
Female
Glucose blood level
Glycemic control
Headache
Hemoglobin blood level
Hispanic
Human
Hyperlipidemia
Hypertension
Impaired glucose tolerance
Influenza
Major clinical study
Male
Multicenter study
Nausea
Primary hyperlipidemia
Protein blood level
Randomized controlled trial
Treatment duration
Treatment planning
Upper abdominal pain
Blood
Clinical trial
Controlled clinical trial
Ethnology
Hispanic
Treatment outcome
Allylamine
Anticholesteremic Agents
Apolipoproteins B
Blood Glucose
Double-Blind Method
Female
Hispanic Americans
Humans
Hyperlipidemias
Male
Prediabetic State
Treatment Outcome
Colesevelam
Hispanic
Hyperlipidemia
Prediabetes
Glycosylated
LDL
HDL
Cholesterol
Hemoglobin A
Lipoproteins

Rights

License

Abierto (Texto Completo)